Commonwealth Equity Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-38,148
Closed -$3.87M 4354
2025
Q4
$3.87M Sell
38,148
-40,158
-51% -$3.22M 0.01% 1503
2025
Q3
$4.28M Buy
78,306
+313
+0.4% +$15.6K 0.01% 1460
2025
Q2
$4.14M Sell
77,993
-16,078
-17% -$817K 0.01% 1453
2025
Q1
$4.07M Buy
94,071
+2,445
+3% +$124K 0.01% 1413
2024
Q4
$5.15M Sell
91,626
-5,097
-5% -$317K 0.01% 1218
2024
Q3
$6.59M Sell
96,723
-8,360
-8% -$472K 0.01% 1051
2024
Q2
$4.44M Buy
105,083
+12,844
+14% +$707K 0.01% 1263
2024
Q1
$6.37M Buy
92,239
+15,825
+21% +$1M 0.01% 1028
2023
Q4
$5.65M Buy
76,414
+2,820
+4% +$185K 0.01% 1035
2023
Q3
$5.02M Sell
73,594
-230
-0.3% -$19.5K 0.01% 1033
2023
Q2
$6.93M Buy
73,824
+431
+0.6% +$33.6K 0.01% 864
2023
Q1
$4.98K Sell
73,393
-2,542
-3% -$163K 0.01% 1008
2022
Q4
$3.76M Sell
75,935
-653
-0.9% -$26.7K 0.01% 1122
2022
Q3
$2.49M Buy
76,588
+3,174
+4% +$131K 0.01% 1286
2022
Q2
$2.89M Buy
73,414
+1,618
+2% +$86.5K 0.01% 1198
2022
Q1
$5.02M Sell
71,796
-2,060
-3% -$151K 0.01% 944
2021
Q4
$5.75M Buy
73,856
+1,338
+2% +$118K 0.01% 864
2021
Q3
$6.92M Buy
72,518
+8,097
+13% +$855K 0.02% 702
2021
Q2
$8.01M Buy
64,421
+11,567
+22% +$1.38M 0.02% 645
2021
Q1
$6.96M Buy
52,854
+10,707
+25% +$1.47M 0.02% 634
2020
Q4
$5.58M Sell
42,147
-3,776
-8% -$457K 0.02% 680
2020
Q3
$4.68M Sell
45,923
-3,070
-6% -$265K 0.02% 672
2020
Q2
$4.26M Buy
48,993
+95
+0.2% +$7.59K 0.02% 665
2020
Q1
$2.84M Buy
48,898
+10,272
+27% +$834K 0.01% 739
2019
Q4
$3.57M Buy
38,626
+11,128
+40% +$978K 0.01% 743
2019
Q3
$2.48M Buy
27,498
+1,266
+5% +$144K 0.01% 861
2019
Q2
$3.1M Sell
26,232
-1,376
-5% -$139K 0.01% 750
2019
Q1
$2.39M Buy
27,608
+349
+1% +$29.7K 0.01% 846
2018
Q4
$1.72M Buy
27,259
+5,986
+28% +$411K 0.01% 921
2018
Q3
$1.68M Buy
21,273
+2,193
+11% +$143K 0.01% 1017
2018
Q2
$1.14M Buy
19,080
+2,731
+17% +$147K 0.01% 1206
2018
Q1
$659K Sell
16,349
-25
-0.2% -$1.22K ﹤0.01% 1509
2017
Q4
$860K Buy
16,374
+2,801
+21% +$150K ﹤0.01% 1321
2017
Q3
$640K Sell
13,573
-4,150
-23% -$167K ﹤0.01% 1455
2017
Q2
$627K Buy
17,723
+1,501
+9% +$46.3K ﹤0.01% 1417
2017
Q1
$383K Sell
16,222
-9,911
-38% -$196K ﹤0.01% 1691
2016
Q4
$349K Sell
26,133
-2,206
-8% -$35.6K ﹤0.01% 1664
2016
Q3
$526K Buy
28,339
+9,962
+54% +$176K ﹤0.01% 1351
2016
Q2
$225K Sell
18,377
-1,103
-6% -$8.31K ﹤0.01% 1877
2016
Q1
$131K Sell
19,480
-1,440
-7% -$9.21K ﹤0.01% 2021
2015
Q4
$193K Sell
20,920
-8,630
-29% -$80.2K ﹤0.01% 1888
2015
Q3
$532K Sell
29,550
-2,791
-9% -$64.1K 0.01% 1209
2015
Q2
$962K Buy
+32,341
New +$812K 0.01% 982

Other funds holding EXAS

Commonwealth Equity Services's EXAS Position: Q1 2026 in Review

Commonwealth Equity Services sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 38,148 shares — an estimated $3.87M sold.

Commonwealth Equity Services first reported a position in EXAS in Q2 2015 and held it in 43 quarters. The position peaked at $8.01M in Q2 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Commonwealth Equity Services reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Commonwealth Equity Services sold 38,148 Exact Sciences shares in Q1 2026, an estimated $3.87M.
  • Commonwealth Equity Services first reported a position in Exact Sciences in Q2 2015 and held it in 43 quarters.
  • Commonwealth Equity Services's Exact Sciences position peaked at $8.01M in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.